QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 deutsche-bank-maintains-buy-on-bwx-technologies-raises-price-target-to-113

Deutsche Bank analyst Scott Deuschle maintains BWX Technologies (NYSE:BWXT) with a Buy and raises the price target from $112...

 bwx-technologies-q2-2024-adj-eps-082-beats-075-estimate-sales-681465m-beat-639313m-estimate

BWX Technologies (NYSE:BWXT) reported quarterly earnings of $0.82 per share which beat the analyst consensus estimate of $0.75 ...

 barclays-downgrades-bwx-technologies-to-underweight-raises-price-target-to-90

Barclays analyst David Strauss downgrades BWX Technologies (NYSE:BWXT) from Equal-Weight to Underweight and raises the price...

 northstar-medical-radioisotopes-bwxt-medical-sign-multi-year-master-services-agreement-which-will-facilitate-the-production-of-ac-225

Actinium-225 (Ac-225) is a critical medical isotope used to kill cancer cells while minimizing the impact to healthy tissues.

 bwxt-medical-and-northstar-partner-to-produce-cancer-fighting-isotope-ac-225

BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc. (NYSE:BWXT) and NorthStar Medical Radioisotopes, LLC (NorthStar) toda...

 janney-montgomery-scott-initiates-coverage-on-bwx-technologies-with-buy-rating-announces-price-target-of-113

Janney Montgomery Scott analyst Thomas Meric initiates coverage on BWX Technologies (NYSE:BWXT) with a Buy rating and announ...

 btig-initiates-coverage-on-bwx-technologies-with-buy-rating-announces-price-target-of-110

BTIG analyst Andre Madrid initiates coverage on BWX Technologies (NYSE:BWXT) with a Buy rating and announces Price Target of...

 bwx-technologies-awarded-phase-two-microreactor-evaluation-contract-for-state-of-wyoming-20m-total-value-of-cost-share-program-and-phase-two-expected-completion-by-q3-2025

Support Strong Among Wyoming Stakeholders and Potential Vendors During Phase One of Cost-Share Program

Core News & Articles

BWX Technologies, Inc. (NYSE:BWXT) today announced a contract award from the U.S. Department of Energy, National Nuclear Securi...

 deutsche-bank-maintains-buy-on-bwx-technologies-lowers-price-target-to-107

Deutsche Bank analyst Scott Deuschle maintains BWX Technologies (NYSE:BWXT) with a Buy and lowers the price target from $110...

 jim-cramer-isnt-recommending-slb-and-blackberry-nothing-there

Jim Cramer is not going to recommend Schlumberger, as it has "got too much business that is not acting well right now."...

 bwx-technologies-submits-drug-master-file-to-us-food-and-drug-administration-for-no-carrier-added-actinium-225-active-pharmaceutical-ingredient

BWXT Medical Ltd. has submitted a Drug Master File (DMF) to the U.S. Drug and Food Administration (FDA) for No Carrier Added (n...

 clsa-initiates-coverage-on-bwx-technologies-with-buy-rating

CLSA analyst Max Hopkins initiates coverage on BWX Technologies (NYSE:BWXT) with a Buy rating.

 deutsche-bank-maintains-buy-on-bwx-technologies-lowers-price-target-to-110

Deutsche Bank analyst Scott Deuschle maintains BWX Technologies (NYSE:BWXT) with a Buy and lowers the price target from $111...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION